IIM-Visakhapatnam launches Young Scientists Induction Training Programme

IMT News Desk
IMT News Desk
· 3 min read

55 young scientists from DST, DBT, CSIR, DAE, ICMR and DRDO attended the programme

The Capacity Building Commission (CBC) in collaboration with the Office of the Principal Scientific Adviser (Office of PSA) to the Government of India launched the Young Scientists Induction Training Programme at the Indian Institute of Management Visakhapatnam (IIM-V).

The first-of-its-kind training programme that envisages honing the capacities of young scientists and science administrators in managing S&T programmes, projects, products, and people; promoting cross-fertilization of ideas among participants; providing practical exposure to new-age research and technology concepts and enhancing functional, behavioural and domain skills.

The programme was initiated at the behest of Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh to institutionalise early career training opportunities for young scientists across the S&T sectors. It is a hybrid training module designed and curated by IIM-V with a mix of online and on-campus activities delving into aspects such as strategy and policy skills, system skills, soft skills, and societal relevance skills.

The first cohort for this programme is being attended by over 55 young scientists from different labs and centres of the Department of Science and Technology (DST), Department of Biotechnology (DBT), Council for Scientific and Industrial Research (CSIR), Department of Atomic Energy (DAE), Indian Council of Medical Research (ICMR) and Defence Research and Development Organisation (DRDO).

Participants shall undergo training spread across four modules involving activities like expert interaction, visits to labs and research facilities, collaborative exercises, etc. A year-round calendar is being developed by IIM-V to cover the scientific workforce spread across the country.

Prof M Chandrasekhar, Director, IIM Vizag welcomed all participants and provided a brief snapshot of the programme and speakers. He informed that experts from across the country have been co-opted to impart the various training modules which will be ultimately uploaded on the iGOT platform for reach across the government.

This was followed by a presentation by Shyama Prasad Roy, Secretary, Capacity Building Commission about the evolving role of the state from a provider of services to a participatory government mechanism. He outlined the importance of capacity building under Mission Karmayogi in achieving governance targets and activities performed across the government to rationalise demand and supply gaps, and the implementation of unique capacity-building models, including the role of the iGOT platform for providing wider access to various training modules for capacity building.

Dr Arabinda Mitra, Distinguished Fellow, Office of PSA, in his keynote address, emphasised the need for all scientific departments and laboratories to keep their doors open towards adopting new age capacities and skills for its workforce. This will be critical in achieving contemporary national goals and meeting the aspirations of the people and polity using science, technology, and innovation.

Dr Parvinder Maini, Scientific Secretary, Office of PSA in her inaugural address asserted that capacity building exercise for young scientists is a watershed moment that will help them to re-assess and re-align their thought process and work trajectory to deliver on national priorities and missions. Due to the rapidly evolving technology landscape and associated ecosystem, training and learning must be a continuous process to empower our future scientific workforce. This would help in driving the creation of new technologies, products, and solutions that address local and global challenges and achieve the socio-economic growth of the country.

 

Read Next

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet
News
April 16, 2026

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet

India’s stroke crisis demands urgent action, and the Indian Stroke Association (ISA) is leading the charge with a bold proposal for a unified national helpline. The ISA presented a comprehensive plan to strengthen stroke care delivery at a FICCI-hosted meeting attended by policymakers, healthcare leaders, and clinical experts. The plenary session, “Strengthening Stroke Care Delivery,” […]
Article by: IMT News Desk
Ivory raises fresh capital to strengthen deep tech offerings
News
April 16, 2026

Ivory raises fresh capital to strengthen deep tech offerings

Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical and IP capabilities. The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched […]
Article by: IMT News Desk
Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition
News
April 16, 2026

Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition

Rubicon Research Limited today announced the acquisition of an 85% equity ownership in Arinna Lifesciences Limited from its current shareholders. With a portfolio of over 60 brands in chronic therapies, Arinna is one of the few domestic formulation companies principally focused on drugs treating conditions of the central nervous system (“CNS”) with more than 4,000 […]
Article by: IMT News Desk
MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide
News
April 16, 2026

MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide

MSN Laboratories has launched SEMABEST, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). SEMABEST is priced at nearly 50% lower than the innovator drug, significantly improving affordability and patient access. The therapy is available as a pre-filled pen for subcutaneous administration. In this evolving landscape, SEMABEST […]
Article by: IMT News Desk